K08670608
Kromasil® AmyCoat® Chiral HPLC Column
5 μm particle size, L × I.D. 50 mm × 4.6 mm
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
NB.21
product line
Kromasil®
manufacturer/tradename
Kromasil® KRWP-5-AmyCoat-4.6X50
availability
available only in USA, Canada and Puerto Rico
parameter
0-40 °C temperature
50 bar pressure (725 psi)
technique(s)
HPLC: suitable
L × I.D.
50 mm × 4.6 mm
matrix active group
carbamoyl phase
particle size
5 μm
pore size
>1000 Å
separation technique
chiral
Looking for similar products? Visit Product Comparison Guide
Legal Information
AmyCoat is a registered trademark of EKA Chemicals AB
Kromasil is a registered trademark of EKA Chemicals AB
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.
If you need assistance, please contact Customer Support
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Zeid A Al-Othman et al.
Biomedical chromatography : BMC, 26(6), 775-780 (2011-10-28)
A fast, economic, reproducible, accurate, effective, rugged and selective chiral-HPLC method was developed and validated for the enantiomeric resolution of nebivolol enantiomers [(+)-RRRS and (-)-SSSR)] in dosage formulation. The method was rapid as chiral separation occurred within only 12 min.
Imran Ali et al.
Chirality, 22(1), 24-28 (2009-02-12)
Sixteen beta-adrenergic antagonists namely acebutalol, alprenolol, atenolol, bisoprolol, bopindolol, bufurolol, carazolol, celiprolol, indenolol, metaprolol, nebivolol, oxprenolol, practolol, propranolol, tertalol, and timolol, and two beta-adrenergic agonists namely cimeterol and clenbuterol were resolved on AmyCoat (150 x 46 mm, 3 microm size
Michal Douša et al.
Journal of separation science, 34(12), 1402-1406 (2011-05-07)
Separation of veterinary drug alaptide ((S)-8-methyl-6,9-diazaspiro(4,5)decane-7,10-dione) from a chiral impurity (R-enantiomer) was developed. Five chiral columns (three amylose and two cellulose type) were evaluated in a reversed-phase system. Three of them offered satisfactory enantiomeric resolution. Finally, three methods were validated
Chiral liquid chromatography?tandem mass spectrometry assay to determine that dexpramipexole is not converted to pramipexole in vivo after administered in humans
Wei, Dong, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 971, 133-140 (2014)
Martin Enmark et al.
Journal of chromatography. A, 1240, 123-131 (2012-05-01)
Enantiomeric separation of omeprazole has been extensively studied regarding both product analysis and preparation using several different chiral stationary phases. In this study, the preparative chiral separation of omeprazole is optimized for productivity using three different columns packed with amylose
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service